• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嵌合免疫球蛋白-T细胞受体蛋白形成功能性受体:对T细胞受体复合物形成和激活的影响。

Chimeric immunoglobulin-T cell receptor proteins form functional receptors: implications for T cell receptor complex formation and activation.

作者信息

Goverman J, Gomez S M, Segesman K D, Hunkapiller T, Laug W E, Hood L

机构信息

Division of Biology, California Institute of Technology, Pasadena 91125.

出版信息

Cell. 1990 Mar 23;60(6):929-39. doi: 10.1016/0092-8674(90)90341-b.

DOI:10.1016/0092-8674(90)90341-b
PMID:2138514
Abstract

We constructed chimeric receptor chains in which an immunoglobulin heavy chain variable region (VH) from a phosphorylcholine-specific antibody is substituted for T cell receptor (Tcr) alpha and beta V regions. We demonstrate that the VH region joined to either the C alpha or the C beta region can form stable chimeric proteins in EL4 T cells. Both chimeric receptor chains associate with CD3 polypeptides in functional receptor complexes and respond to phosphorylcholine coupled to Sepharose beads. The VH-C alpha chimeric chain associates with the EL4 beta chain, while the VH-C beta chimeric protein appears to form either a homodimer or a heterodimer with the native EL4 beta chain. Thus, functional receptor complexes can be formed using two C beta regions, and the C alpha region may not be required for CD3 association and surface expression of Tcr complexes.

摘要

我们构建了嵌合受体链,其中来自磷酸胆碱特异性抗体的免疫球蛋白重链可变区(VH)取代了T细胞受体(Tcr)的α和β可变区。我们证明,与Cα或Cβ区域连接的VH区域可在EL4 T细胞中形成稳定的嵌合蛋白。两种嵌合受体链都在功能性受体复合物中与CD3多肽结合,并对偶联到琼脂糖珠上的磷酸胆碱产生反应。VH-Cα嵌合链与EL4β链结合,而VH-Cβ嵌合蛋白似乎与天然EL4β链形成同二聚体或异二聚体。因此,使用两个Cβ区域可以形成功能性受体复合物,并且CD3结合和Tcr复合物的表面表达可能不需要Cα区域。

相似文献

1
Chimeric immunoglobulin-T cell receptor proteins form functional receptors: implications for T cell receptor complex formation and activation.嵌合免疫球蛋白-T细胞受体蛋白形成功能性受体:对T细胞受体复合物形成和激活的影响。
Cell. 1990 Mar 23;60(6):929-39. doi: 10.1016/0092-8674(90)90341-b.
2
Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.免疫球蛋白-T细胞受体嵌合分子作为具有抗体类型特异性的功能性受体的表达。
Proc Natl Acad Sci U S A. 1989 Dec;86(24):10024-8. doi: 10.1073/pnas.86.24.10024.
3
Secretion of a soluble, chimeric gamma delta T-cell receptor-immunoglobulin heterodimer.可溶性嵌合γδ T细胞受体-免疫球蛋白异二聚体的分泌
Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6871-5. doi: 10.1073/pnas.89.15.6871.
4
Expression of chimeric receptor composed of immunoglobulin-derived V regions and T-cell receptor-derived C regions.由免疫球蛋白衍生的V区和T细胞受体衍生的C区组成的嵌合受体的表达。
Biochem Biophys Res Commun. 1987 Dec 31;149(3):960-8. doi: 10.1016/0006-291x(87)90502-x.
5
Regions of the T cell receptor alpha and beta chains that are responsible for interactions with CD3.负责与CD3相互作用的T细胞受体α链和β链区域。
J Exp Med. 1991 May 1;173(5):1247-56. doi: 10.1084/jem.173.5.1247.
6
Lysine 271 in the transmembrane domain of the T-cell antigen receptor beta chain is necessary for its assembly with the CD3 complex but not for alpha/beta dimerization.T细胞抗原受体β链跨膜结构域中的赖氨酸271对于其与CD3复合物的组装是必需的,但对于α/β二聚化不是必需的。
J Biol Chem. 1990 Mar 5;265(7):4131-5.
7
Assembly and function of the T cell antigen receptor. Requirement of either the lysine or arginine residues in the transmembrane region of the alpha chain.T细胞抗原受体的组装与功能。α链跨膜区赖氨酸或精氨酸残基的需求。
J Biol Chem. 1990 Aug 15;265(23):14036-43.
8
Requirements for cell surface expression of the human TCR/CD3 complex in non-T cells.非T细胞中人TCR/CD3复合物细胞表面表达的要求。
Int Immunol. 1991 Apr;3(4):359-68. doi: 10.1093/intimm/3.4.359.
9
Structure of the T-cell antigen receptor: evidence for two CD3 epsilon subunits in the T-cell receptor-CD3 complex.T细胞抗原受体的结构:T细胞受体-CD3复合物中存在两个CD3ε亚基的证据。
Proc Natl Acad Sci U S A. 1990 Sep;87(18):7220-4. doi: 10.1073/pnas.87.18.7220.
10
Immunoglobulin heavy-chain and CD3 delta-chain gene enhancers are DNase I-hypersensitive in hemopoietic progenitor cells.免疫球蛋白重链和CD3δ链基因增强子在造血祖细胞中对DNA酶I敏感。
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3424-8. doi: 10.1073/pnas.89.8.3424.

引用本文的文献

1
Engineered CAR-NK Cells for Cancer Immunotherapy: Lentiviral-Based CAR Transduction of NK-92 Cells.用于癌症免疫治疗的工程化嵌合抗原受体自然杀伤细胞:基于慢病毒的NK-92细胞嵌合抗原受体转导
Methods Mol Biol. 2025;2930:267-275. doi: 10.1007/978-1-0716-4558-1_19.
2
Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm.靶向CD123和CD303的免疫疗法:治疗母细胞样浆细胞样树突状细胞瘤的新前沿。
Int J Mol Sci. 2025 Mar 18;26(6):2732. doi: 10.3390/ijms26062732.
3
Chimeric Antigen Receptor (CAR) T-Cell Therapy in Hematologic Malignancies: Clinical Implications and Limitations.嵌合抗原受体(CAR)T细胞疗法在血液系统恶性肿瘤中的应用:临床意义与局限性
Cancers (Basel). 2024 Apr 22;16(8):1599. doi: 10.3390/cancers16081599.
4
Unlocking the Potential of Induced Pluripotent Stem Cells in Revolutionizing Cancer Therapy.释放诱导多能干细胞在革新癌症治疗方面的潜力。
Curr Stem Cell Res Ther. 2025;20(4):360-376. doi: 10.2174/011574888X294791240408055222.
5
Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell-Mediated Cytotoxicity.颗粒酶 F:嵌合抗原受体 T 细胞介导的细胞毒性的耗竭标志物和调节剂。
J Immunol. 2024 Apr 15;212(8):1381-1391. doi: 10.4049/jimmunol.2300334.
6
Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123.由于精准靶向 CD123,在原始浆细胞样树突细胞肿瘤癌症治疗方面取得突破。
Int J Mol Sci. 2024 Jan 25;25(3):1454. doi: 10.3390/ijms25031454.
7
Application of single-cell sequencing to the research of tumor microenvironment.单细胞测序在肿瘤微环境研究中的应用。
Front Immunol. 2023 Oct 27;14:1285540. doi: 10.3389/fimmu.2023.1285540. eCollection 2023.
8
Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer.利用新策略和细胞类型克服癌症过继细胞治疗中的免疫耐受。
J Immunother Cancer. 2023 Apr;11(4). doi: 10.1136/jitc-2022-006434.
9
CD123 and More: How to Target the Cell Surface of Blastic Plasmacytoid Dendritic Cell Neoplasm.CD123及其他:如何靶向浆细胞样树突状细胞肿瘤的细胞表面
Cancers (Basel). 2022 May 3;14(9):2287. doi: 10.3390/cancers14092287.
10
Development of CAR T Cell Therapy in Children-A Comprehensive Overview.儿童嵌合抗原受体T细胞疗法的发展——全面概述
J Clin Med. 2022 Apr 12;11(8):2158. doi: 10.3390/jcm11082158.